Recreational drug misuse and stroke

Current Drug Abuse Reviews

Volumn 4, Issue 4, 2011, Pages 286-291

  Yeung, Michael ^a   Bhalla, Ajay ^a   Birns, Jonathan ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Amphetamines; Anabolic steroids; Cannabis; Cocaine; Heroin; Mephedrone; Recreational drugs; Stroke

Indexed keywords

4 HYDROXYBUTYRIC ACID; 4' METHYLMETHCATHINONE; AMPHETAMINE; ANABOLIC AGENT; CANNABIS; CATHINONE; COCAINE; DIAMORPHINE; OPIATE; RECREATIONAL DRUG;

ANTEROGRADE AMNESIA; ATTENTION DEFICIT DISORDER; BLOOD VESSEL INJURY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN VASCULITIS; BRAIN VASOSPASM; CARDIOMYOPATHY; CHRONIC PAIN; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG EFFECT; DRUG MECHANISM; DRUG MISUSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPHASIA; FEVER; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXIA; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TACHYCARDIA;

EID: 83455220521     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473711104040286     Document Type: Review

References (71)

1. Albers GW, Caplan LR, Easton JD, et al. TIA Working Group: Transient ischemic attack - proposal for a new definition. N Engl J Med 2002; 347: 1713-6.
2. Department of Health: National Stroke Strategy 2007.
3. Sudlow CLM, Warlow CP, for the International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997; 28: 491-99.
4. Feigin VL, Lawes CMM, Bennett DA, Anderson CA. Stroke epidemiology: a review of population based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003; 2: 43-53.
5. Office of National Statistics. Mortality statistics causes. England and Wales, Series DH2 No 24. London HMSO, 1997.
6. Schifano F. Is urbanization a risk factor for substance misuse? Current Opinion in Psychiatry 2008; 21: 391-7.
7. Substance Abuse and Mental Health Services Administration. The NSDUH report: metamphetamine use, abuse, and dependence: 2002, 2003, and 2004. http://www.oas.samhsa.gov/nsduh/2k4nsduh/2k4overview/2k4overview.pdf (accessed 12 October, 2010).
8. Hoare J, Moon D. Drug Misuse Declared. Findings from the 2009/10 British Crime Survey England and Wales. http://rds.homeoffice.gov.uk/rds/pdfs10/hosb1310.pdf (accessed 2 November, 2010)
9. Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine. A population based study of hospitalized patients. Arch Gen Psychiatry 2007; 64: 495-502.
10. Warner EA. Cocaine abuse. Ann Intern Med 1993; 119: 226-35.
11. Benowitz NL. Clinical pharmacology and toxicology of cocaine. PharmacolToxicol 1993; 72: 3-12.
12. Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med J 2007; 83: 389-394
13. Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the 'crack' form of alkaloidal cocaine. N Engl J Med 1990; 323: 699-704.
14. Wallace EA, Wisniewski G, Zubal G, et al. Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology 1996; 128: 17-20.
15. Johnson B, Lamki L, Fang B, et al. Demonstration of dosedependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology 1998; 18: 377-84.
16. Simpson RW, Edwards WD. Pathogenesis of cocaine-induced ischemic heart disease. Arch Pathol Lab Med 1986; 110: 479-84.
17. Konzen JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke 1995; 26: 1114-8.
18. Heesch CM, Wilhelm CR, Ristich J, et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000; 83: 688-95.
19. Kolodgie FD, Virmani R, Cornhill, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine associated coronary vasospasm and thrombosis. J Am Coll Cardiol 1991; 17: 1553-60.
20. Restrepo CS, Rojas CA, Martinez S, et al. Cardiovascular complications of cocaine: Imaging findings. Emerg Radiol 2009; 16: 11-9.
21. Zandio B, Erro M, Cabada T, et al. Cocaine-induced brain stem stroke associated to cranial midline destructive lesions. Neurologica 2008; 23: 55-8.
22. Kaye BR, Fainstat M. Cerebral vasculitis associated with cocaine abuse. JAMA 1987; 258: 2104.
23. Chakko S, Sepulveda S, Kessler KM, et al. Frequency and type of electrocardiographic abnormalities in cocaine abuse. Am J Cardiol 1994; 74: 710-3.
24. Sloan MA, Mattioni TA. Concurrent myocardial and cerebral infarctions after intranasal cocaine use. Stroke 1992; 23: 427-30.
25. Sauer CM. Recurrent embolic stroke and cocaine related cardiomyopathy. Stroke 1991; 22: 1203-5.
26. Green RM, Kelly KM, Gabrielsen T, et al. Multiple intracerebral hemorrhages after smoking 'crack' cocaine. Stroke 1990; 21: 657-62.
27. Schwartz KA, Cohen JA. Subarachnoid haemorrhage precipitated by cocaine snorting. Arch Neurol 1984; 41: 705.
28. Broderick JP, Viscoli CM, Brott T, et al. Major risk factors for aneurysmal subarachnoid haemorrhage in the young are modifiable. Stroke 2003; 34: 1375-81.
29. Caplan CR, Hier DB, Banks G. Current concepts of cerebrovascular disease - Stroke: Stroke and drug abuse. Stroke 1982; 13: 869-72.
30. Toossi S, Hess CP, Hills NK, Josephson SA. Neurovascular complications of cocaine use at a tertiary stroke centre. J Stroke CerebrovascDis 2010; 19: 273-8.
31. Zuckerman GB, Ruiz DC, Keller IA, Brooks J. Neurologic complications following intranasal administration of heroin in an adolescent. Ann Pharmacotherapy 1996; 30: 778-81.
32. Brust JCM, Richter RW. Stroke associated with addiction to heroin. J NeurolNeurosurg Psychiatry 1976; 39: 194-9.
33. Buttner A, Mall G, Penning R, Weis S. The neuropathology of heroin abuse. Forensic SciInt 2000; 113: 435-42.
34. Fatovich DM, McCoubrie D, Song S, et al. Lesions are seen in young users of stimulant drugs. BMJ 2010; 341: c5636.
35. Citron BP, Halpern M, McCarron M, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970; 283: 1003-11.
36. Citron BP, Peters RL. Angiitis in drug abusers. N Engl J Med 1971; 284: 112.
37. Wang AM, Suojanen JN, Colucci VM, et al. Cocaine and metamphetamine induced acute cerebral vasospasm: an angiographic study in rabbits. Am J Neuroradiol 1990; 11: 1141-6.
38. Vallee JN, Crozier S, Guillevin R, et al. Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser. Neurology 2003; 61: 839-41.
39. Martinez N, Diez-Tejedor E, Frank A. Vasospasm/thrombus in cerebral ischemia related to cocaine use. Stroke 1996; 27: 147-8.
40. Schteinschnaider A, Lemme-Plaghos L, Garbugino S, et al. Cerebral arteritis following methylphenidate use. J Child Neurol 2000; 15: 265-7.
41. Kokkinos J, Levine SR. Possible association of ischemic stroke with phentermine. Stroke 1993; 24: 310-3.
42. US Food and Drug Administration. Legal requirements for the sale and purchase of drug products containing pseudoephedrine, ephedrine, and phenylpropanolamine. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm072423.htm (accessed 12 October, 2010).
43. Thanvi BR, Treadwell SD. Cannabis and stroke: is there a link? Postgrad Med J 2009; 85: 80-3.
44. Mateo I, Pinedo A, Gomez-Beldarrain, et al. Recurrent stroke associated with cannabis use. J Neurol Neurosur Ps 2005; 76: 435-7.
45. Lawson TM, Rees A. Stroke and transient ischemic attacks in association with substance abuse in a young man. Postgrad Med J 1996; 72: 692-3.
46. Zachariah SB. Stroke after heavy marijuana smoking. Stroke 1991; 22: 406-9.
47. Kunos G, Jarai Z, Batkai S, et al. Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 2000; 108: 159-68.
48. Clark S. Marijuana and the cardiovascular system. Pharmacol Biochem Be 1974; 3: 299-306.
49. Mathew RJ, Wilson WH, Tant SR. Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand 1989; 79: 118-28.
50. White D, Martin D, Geller T, Pittman T. Stroke associated with marijuana abuse. Pediatr Neurosurg 2000; 32: 92-4.
51. Wilson RJ, Humphreys D, Lowe JV, Wiethe KE. Middle cerebral artery velocity during upright posture after marijuana smoking. Acta Psychiatr Scand 1992; 86: 173-8.
52. Tunving K, Thulin O, Risberg J, et al. Regional cerebral bloodflow in long term heavy cannabis use. Psychiatr Res 1986; 17: 15-21.
53. Mesec A, Rot U, Grad A, et al. Cerebrovascular disease associated with marijuana abuse: a case report. Cerebrovasc Dis 2001; 11: 284-5.
54. Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130: 3091-101.
55. Disdier P, Granel B, Serratrice J, et al. Cannabis arteritis revisited - ten new case reports. Angiology 2001; 52: 1-5.
56. Fisher BAC, Ghuran A, Vadamalai V, et al. Cardiovascular complications induced by cannabis smoking: a case reportand review of the literature. Emerg Med J 2005; 22: 679-80.
57. Singh GK. Atrial fibrillation associated with marijuana use. Pediatr Cardiol 2000; 21: 284.
58. Mittelman MA, Lewis RA, Maclure M, et al. Triggering myocardial infarction by marijuana. Circulation 2001; 103: 2805-9.
59. Winstock AR, Marsden J, Mitcheson L. What should be done about mephedrone? BMJ 2010; 340: c1605.
60. Advisory Council on the Misuse of Drugs. Consideration of the Cathinones. http://www.homeoffice.gov.uk/publications/drugs/acmd1/acmdcathinodes-report-2010?view=Binary (accessed 2 November, 2010).
61. Cozzi NV, Sievert MK, Shulgin AT, et al. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 1999; 381: 63-9.
62. Nagai F, Nonaka R, Kamimura KSH. The effects of non-medically used drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 2007; 559: 132-7.
63. Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H. Overview of amphetamine-type stimulant mortality data-UK, 1997-2007. Neuropsychobiology 2010; 61: 122-30.
64. Wood DM, Greene SL, Dargan PI. Plant food and bath salts - How harmful is mephedrone? Clin Toxicol 2010; 48: 616.
65. Sammler EM, Foley PL, Lauder GD, et al. A harmless high? Lancet 2010; 376: 742.
66. 2010 No.1207. Dangerous Drugs. The Misuse of Drugs Act 1971 (Amendment) Order 2010 http://www.legislation.gov.uk/uksi/2010/1207/pdfs/uksi_20101207_en.pdf (accessed 2 November 2010).
67. Becker RC, Ansell J. Cardiovascular effects of anabolic steroids. Primary Cardiology 1994; 20: 26-7.
68. Santamarina RD, Besocke AG, Romano LM, et al. Iscahemic stroke related to anabolic abuse. Clin Neuropharmacol 2008; 31: 80-5.
69. Stergiopoulos K, Brennan JJ, Mathews R, et al. Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature. Vasc Health Risk Manage 2008; 4: 1475-80.
70. Ferenchick G, Schwartz D, Ball M, et al. Androgenic-anabolic steroid abuse and platelet aggregation: A pilot study in weight lifters. Am J Med Sci 1992; 303: 78-82.
71. Frankle MA, Eichberg R, Zachariah SB. Anabolic androgenic steroids and a stroke in an athlete: Case report. Arch Phys Med Rehab 1988; 69: 632-3.